|Articles|May 1, 2007
- Pharmaceutical Executive-05-01-2007
- Volume 0
- Issue 0
The Pharm Exec 50: Holding Pattern
The top 50 pharmaceutical companies, ranked by prescription pharmaceutical drug sales, plus rankings of top products, R&D spend, and more.
Advertisement
Articles in this issue
over 18 years ago
Kid Tested, Government Approved?over 18 years ago
Leadership: Getting on Boardover 18 years ago
Spend Trends 2007: Hang 10over 18 years ago
The Secretover 18 years ago
Marketing to Professionals: No Sales Force, No Problemover 18 years ago
Opinion: Are Price Controls the New Black?over 18 years ago
Toolkit: How To Be a Better Partnerover 18 years ago
Washington Report: Pathways for Proteinsover 18 years ago
Global Report: Pure and Simpleover 18 years ago
Thoughtleader: Thomas Nagle, Monitor GroupNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: Bristol Myers Squibb’s Continued Growth
2
JP Morgan 2026 Preview: Sanofi Looks to Bolster Future Pipeline
3
JP Morgan 2026 Preview: Novartis’ History of Expansion
4
Data Quality in Drug Development: The Missing Foundation to Realize AI’s Promise in Clinical Trials
5